l-ornithine-l-aspartate

Ukraine

Drugs containing this active substance

  • HEPATOX

    The drug is used to treat complications caused by impaired detoxification function of the liver (e.g., in cirrhosis), especially if there are symptoms of hepatic encephalopathy, including impaired consciousness (precoma, coma).

    Form: concentrate for infusion solution

    Active substance Dosage
    l-ornithine-l-aspartate 500 mg/ml

    ATC: A05BA

    Manufacturer: Holopack Verpackungstechnik GmbH (secondary packaging, control; manufacturing of unpackaged products, primary and secondary packaging, control)